News
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate
September 16, 2020
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments during the COVID-19 pandemic, although more research is needed and shared decision making is warranted.
News
Infectious COVID-19 can persist in gut for weeks
September 14, 2020
“We found active and prolonged SARS-CoV-2 infection in the stool of patients with COVID-19, even after recovery, suggesting that coronavirus could remain in the gut of asymptomatic carriers.”
![1]()
News
Performance status, molecular testing key to metastatic cancer prognosis
August 20, 2020
“The applicability of clinical trials data to hospitalized patients is generally poor. That’s an important caveat to keep in mind.”
News
Higher death rate seen in cancer patients with nosocomial COVID-19
July 30, 2020
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
![1]()
News
MIS-C is a serious immune-mediated response to COVID-19 infection
July 28, 2020
Multisystem inflammatory syndrome in children (MIS-C) is still a moving target because there is much still to learn about it.
News
Preliminary evidence indicates famotidine might improve COVID-19 symptoms
June 9, 2020
Apart from two cases of anosmia, symptoms resolved completely within 14 days of starting famotidine.
![1]()
News
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
May 26, 2020
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
![1]()
Opinion
Summary of the IDSA guidelines on the diagnosis of COVID-19
May 14, 2020
Learn about those recommendations that are most relevant to primary care clinicians.
News
Androgens may explain male vulnerability to COVID-19
May 8, 2020
Androgen deprivation therapy may be protective against COVID-19, a study suggests.
News
COVID-19 death rate was twice as high in cancer patients in NYC study
May 5, 2020
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
